Skip to content
Home/Companies/MedTech/Glycotest
Glycotest

Glycotest

MedTech·US·Active·14yr hold
Entry
2012
Hold
14yr
Status
Active

Who owns Glycotest?

Glycotest is currently owned by EMV Capital through EMV Capital Evergreen Fund (2012 vintage), since 2012.

Hand-verified · updated 2026-07-17

EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUnited States
SectorMedTech
StatusActive
Websitewww.glycotest.com

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

Dogtooth Technologies
Active
TMTUK· 2026
AMR Bio
AMR Bio
Active
BiotechUK· 2025
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Ventive
Active
TMTUK· 2022
Cetromed
Active
BiotechUK· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Glycotest

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Glycotest.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue